Silinda Neou

477 total citations
3 papers, 15 citations indexed

About

Silinda Neou is a scholar working on Biotechnology, Immunology and Biomedical Engineering. According to data from OpenAlex, Silinda Neou has authored 3 papers receiving a total of 15 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Biotechnology, 3 papers in Immunology and 2 papers in Biomedical Engineering. Recurrent topics in Silinda Neou's work include Cancer Research and Treatments (3 papers), Immune cells in cancer (3 papers) and Nanoplatforms for cancer theranostics (2 papers). Silinda Neou is often cited by papers focused on Cancer Research and Treatments (3 papers), Immune cells in cancer (3 papers) and Nanoplatforms for cancer theranostics (2 papers). Silinda Neou collaborates with scholars based in . Silinda Neou's co-authors include Susanne Steggerda, Gisele Marguier, Melissa Works, Weiqun Li, Julie Janes, Mark K. Bennett, Jing Zhang, Matthew Gross, Ethan Emberley and Mirna L.M. Rodriguez and has published in prestigious journals such as Cancer Research, European Journal of Cancer and Cancer Immunology Research.

In The Last Decade

Silinda Neou

3 papers receiving 15 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silinda Neou	3	8	7	4	4	3	3	15
Lakshmi Chilukuri United States	2	12 1.5×	10 1.4×		4 1.0×	1 0.3×	4	26
Shanmeizi Zhao China	4	13 1.6×	3 0.4×		3 0.8×		13	33
B. Zucker Germany	3	7 0.9×	2 0.3×	1 0.3×	7 1.8×	2 0.7×	4	19
T. Nishiyama Netherlands	2	12 1.5×	2 0.3×		3 0.8×	4 1.3×	2	20
M. Kim United States	2	9 1.1×	4 0.6×				2	13
K. Sawant India	2	3 0.4×	4 0.6×		4 1.0×		2	15
Jessica Lee United States	3	3 0.4×	4 0.6×		7 1.8×		9	14
Olga Tkachenko United Kingdom	3	24 3.0×	6 0.9×	1 0.3×	1 0.3×	3 1.0×	4	40
Zining Wang China	3	6 0.8×	2 0.3×		7 1.8×		12	28
Sabina Desar United States	2	4 0.5×	3 0.4×		6 1.5×		3	12

Countries citing papers authored by Silinda Neou

Since Specialization

Citations

This map shows the geographic impact of Silinda Neou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silinda Neou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silinda Neou more than expected).

Fields of papers citing papers by Silinda Neou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silinda Neou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silinda Neou. The network helps show where Silinda Neou may publish in the future.

Co-authorship network of co-authors of Silinda Neou

This figure shows the co-authorship network connecting the top 25 collaborators of Silinda Neou. A scholar is included among the top collaborators of Silinda Neou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silinda Neou. Silinda Neou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Works, Melissa, Mark K. Bennett, Ethan Emberley, et al.. (2016). Abstract 552: Immuno-oncology agent CB-1158 is a potent and selective arginase inhibitor and causes an immune-mediated anti-tumor response. Cancer Research. 76(14_Supplement). 552–552. 10 indexed citations

2.

Steggerda, Susanne, Mark K. Bennett, Jason Chen, et al.. (2016). Abstract B045: Arginase inhibitor CB-1158 elicits immune-mediated antitumor responses as a single agent and in combination with other immunotherapies. Cancer Immunology Research. 4(11_Supplement). B045–B045. 2 indexed citations

3.

Steggerda, Susanne, Ethan Emberley, Matthew Gross, et al.. (2016). Arginase inhibitor CB-1158 elicits immune-mediated anti-tumor responses as a single agent and enhances the efficacy of other immunotherapies. European Journal of Cancer. 69. S97–S97. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact